JP2004115525A - 抗炎症性化合物の局所搬送用搬送剤 - Google Patents

抗炎症性化合物の局所搬送用搬送剤 Download PDF

Info

Publication number
JP2004115525A
JP2004115525A JP2003338818A JP2003338818A JP2004115525A JP 2004115525 A JP2004115525 A JP 2004115525A JP 2003338818 A JP2003338818 A JP 2003338818A JP 2003338818 A JP2003338818 A JP 2003338818A JP 2004115525 A JP2004115525 A JP 2004115525A
Authority
JP
Japan
Prior art keywords
menthol
composition
camphor
carrier according
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003338818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004115525A5 (enExample
Inventor
Joseph Schwarz
シュワルツ，ジョセフ
Michael Weisspapir
ワイスパピア，マイケル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpharx Inc
Original Assignee
Alpharx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharx Inc filed Critical Alpharx Inc
Publication of JP2004115525A publication Critical patent/JP2004115525A/ja
Publication of JP2004115525A5 publication Critical patent/JP2004115525A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2003338818A 2002-09-27 2003-09-29 抗炎症性化合物の局所搬送用搬送剤 Pending JP2004115525A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/255,951 US7138394B2 (en) 2002-09-27 2002-09-27 Vehicle for topical delivery of anti-inflammatory compounds

Publications (2)

Publication Number Publication Date
JP2004115525A true JP2004115525A (ja) 2004-04-15
JP2004115525A5 JP2004115525A5 (enExample) 2007-02-01

Family

ID=32029201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003338818A Pending JP2004115525A (ja) 2002-09-27 2003-09-29 抗炎症性化合物の局所搬送用搬送剤

Country Status (4)

Country Link
US (3) US7138394B2 (enExample)
JP (1) JP2004115525A (enExample)
CN (1) CN100534530C (enExample)
MX (1) MXPA03008947A (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008013449A (ja) * 2006-07-04 2008-01-24 Taisho Pharmaceut Co Ltd ユビデカレノン含有自己乳化組成物
JP2012523408A (ja) * 2009-04-08 2012-10-04 カディラ・ヘルスケア・リミテッド ジクロフェナクの安定な医薬組成物
WO2015151990A1 (ja) * 2014-03-30 2015-10-08 小林製薬株式会社 外用医薬組成物
JP2015189759A (ja) * 2014-03-30 2015-11-02 小林製薬株式会社 外用医薬組成物
JP2022500446A (ja) * 2018-09-17 2022-01-04 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピックSociete D’Exploitation De Produits Pour Les Industries Chimiques Seppic 少なくとも１つの抗炎症物質を含む局所使用のための医薬組成物
JP2024056733A (ja) * 2018-08-01 2024-04-23 ノビラ・ファーマシューティカルズ・インコーポレイテッド 薬剤を含む共晶溶媒、並びにその製造および使用方法

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
WO2006096955A1 (en) * 2005-03-16 2006-09-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
US20060240051A1 (en) * 2005-04-26 2006-10-26 Singleton Andy H Eutectic blends containing a water soluble vitamin derivative
EP1883390B1 (en) * 2005-05-05 2009-07-29 Reckitt Benckiser Inc. Topical compositions
US20070042007A1 (en) * 2005-08-19 2007-02-22 Joseph Schwarz Topical composition for delivery of salicylate esters
US20070048360A1 (en) * 2005-08-23 2007-03-01 R Carrara Dario N Pharmaceutical compositions with melting point depressant agents and method of making same
GT200600405A (es) * 2005-09-07 2007-04-16 Formula de microemulsión
JP5276448B2 (ja) * 2005-12-22 2013-08-28 オークウッド ラボラトリーズ，エル．エル．シー． 昇華可能な持続放出デリバリーシステム及びその製造方法
DE102006042742A1 (de) * 2006-09-12 2008-03-27 Barnikol-Keuten, Doris, Dr. Nano-Vehikel für den transkutanen Transport, diese enthaltende Zubereitungen und deren Anwendung
CA2666398C (en) 2006-10-17 2015-08-18 Ed Kisak Diclofenac gel
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
CN101524325B (zh) * 2009-04-03 2010-12-29 龚志成 复方薄荷脑微乳及其鼻用制剂
CA2785643A1 (en) 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation
DE102010013064A1 (de) * 2010-03-26 2011-12-15 Gabriele Blume Neuartiges Trägersystem für den Transport von Wirkstoffen in die Haut
EP2457554A1 (de) * 2010-11-24 2012-05-30 Symrise AG Menthol enthaltende Mischung
US9545429B1 (en) 2011-09-03 2017-01-17 Biolyte Laboratories, Llc Homeopathic formulations
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
FR2994386B1 (fr) * 2012-08-07 2016-06-24 Thorel Jean-Noel Inhibition de l'adhesion de micro-organismes pathogenes par un ester de saccharose et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee
EA028959B1 (ru) 2012-12-20 2018-01-31 Юнилевер Н.В. Эвтектические смеси в композициях для личной гигиены
CN104884034B (zh) * 2012-12-20 2017-06-06 荷兰联合利华有限公司 个人护理组合物中的低共熔混合物
PL2950823T3 (pl) * 2013-02-01 2021-02-08 Ddrops Company Ciekłe kompozycje mentolu
WO2014127458A1 (en) * 2013-02-22 2014-08-28 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for transmucosal administration of benzodiazepines
CA2978517A1 (en) 2014-03-04 2015-09-11 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US9623062B2 (en) * 2014-06-27 2017-04-18 Jeju National University Industryacademic Cooperation Foundation Anti-ageing activity of camphor in fibroblast cell line
US10828251B1 (en) 2017-01-14 2020-11-10 Biolyte Laboratories, Llc Homeopathic formulations
US10617634B1 (en) 2017-03-10 2020-04-14 Biolyte Laboratories, Llc Topical homeopathic formulations for menstrual cramps
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface
BR102019014454A2 (pt) * 2018-07-13 2020-02-04 Upl Ltd composição compreendendo mistura eutética de fungicida boscalide e estrobilurina
US20210346302A1 (en) 2018-10-15 2021-11-11 Cipla Limited Pharmaceutical Formulation
US20220142957A1 (en) * 2019-03-21 2022-05-12 Universidade Nova De Lisboa Terpene based therapeutic deep eutectic system, method of obtaining and uses thereof
CA3138194A1 (en) * 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic gel compositions
FR3099697B1 (fr) * 2019-08-09 2022-07-08 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition pharmaceutique à usage topique se présentant sous la forme d’une phase dispersée à base d’au moins un diol court dans une phase grasse continue et comprenant au moins une substance anti-inflammatoire.
US20220079873A1 (en) * 2020-09-11 2022-03-17 Ps Therapy Ltd. Topical compositions and methods of use
US20250099369A1 (en) 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs
CN118084849B (zh) 2024-01-22 2024-07-19 南京默可思泰医药科技有限公司 一种含有麝香草酚及其衍生物的胶束制剂的制备方法和应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562013A (en) * 1978-11-02 1980-05-10 Rakuule Yakuhin Hanbai Kk Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
JPS6112614A (ja) * 1984-06-27 1986-01-21 Lion Corp 水性パップ剤
JPS6388125A (ja) * 1987-08-29 1988-04-19 Rakuule Yakuhin Hanbai Kk インドメタシン配合のパップ剤
JPS63179820A (ja) * 1987-01-22 1988-07-23 Kao Corp 坐剤組成物
JPS63201119A (ja) * 1987-02-17 1988-08-19 Kao Corp 貼付剤組成物
JPH06501013A (ja) * 1990-09-28 1994-01-27 ザ、プロクター、エンド、ギャンブル、カンパニー 蒸気形でのエフェドリンベースのデリバリー用のエフェドリンベース及びサリチル酸アルキル含有組成物
JP2002154952A (ja) * 2000-11-15 2002-05-28 Ikeda Mohandou:Kk ｌ−メントール高含有含水膏剤及びパッチ剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446818A (en) * 1977-09-21 1979-04-13 Lion Dentifrice Co Ltd Surgical antiiinflammatory and anodyne agent
JPS5446816A (en) 1977-09-21 1979-04-13 Kirie Kawasaki Extracting of vitamin c and extracting container
JPS5467022A (en) * 1977-11-07 1979-05-30 Toko Yakuhin Kogyo Kk Topical agent and production thereof
DE3048369C2 (de) * 1980-12-22 1983-01-05 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Abrasiv wirkende Mittel und deren Verwendung
LU84607A1 (fr) 1983-01-26 1984-10-24 Oreal Compositions alcooliques ou hydroalcooliques contenant des essences naturelles et du benzylidene camphre ou ses derives
US4933184A (en) 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US5013726A (en) 1989-09-12 1991-05-07 Ivy Jeffery W External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion
US5124320A (en) 1989-09-12 1992-06-23 Ivy Jeffery W An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion
CA2028496A1 (en) * 1989-10-31 1991-05-01 Tohru Nakao Thiophene compounds and their pharmaceutical uses
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance
DE4027980A1 (de) 1990-09-04 1992-03-05 Merck Patent Gmbh Dialkoxybenzylidenkampfer-derivate
US5322689A (en) 1992-03-10 1994-06-21 The Procter & Gamble Company Topical aromatic releasing compositions
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US6113921A (en) 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US5853768A (en) 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
US5961997A (en) * 1997-03-25 1999-10-05 Swinehart; James M. Antipruritic composition
ATE221770T1 (de) * 1997-05-14 2002-08-15 Galen Chemicals Ltd Topische mittel
KR100595944B1 (ko) * 1998-08-10 2006-07-03 가부시끼가이샤닛뽕하이폭스 소염진통제
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562013A (en) * 1978-11-02 1980-05-10 Rakuule Yakuhin Hanbai Kk Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
JPS6112614A (ja) * 1984-06-27 1986-01-21 Lion Corp 水性パップ剤
JPS63179820A (ja) * 1987-01-22 1988-07-23 Kao Corp 坐剤組成物
JPS63201119A (ja) * 1987-02-17 1988-08-19 Kao Corp 貼付剤組成物
JPS6388125A (ja) * 1987-08-29 1988-04-19 Rakuule Yakuhin Hanbai Kk インドメタシン配合のパップ剤
JPH06501013A (ja) * 1990-09-28 1994-01-27 ザ、プロクター、エンド、ギャンブル、カンパニー 蒸気形でのエフェドリンベースのデリバリー用のエフェドリンベース及びサリチル酸アルキル含有組成物
JP2002154952A (ja) * 2000-11-15 2002-05-28 Ikeda Mohandou:Kk ｌ−メントール高含有含水膏剤及びパッチ剤

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008013449A (ja) * 2006-07-04 2008-01-24 Taisho Pharmaceut Co Ltd ユビデカレノン含有自己乳化組成物
JP2012523408A (ja) * 2009-04-08 2012-10-04 カディラ・ヘルスケア・リミテッド ジクロフェナクの安定な医薬組成物
WO2015151990A1 (ja) * 2014-03-30 2015-10-08 小林製薬株式会社 外用医薬組成物
JP2015189760A (ja) * 2014-03-30 2015-11-02 小林製薬株式会社 外用医薬組成物
JP2015189759A (ja) * 2014-03-30 2015-11-02 小林製薬株式会社 外用医薬組成物
JP2024056733A (ja) * 2018-08-01 2024-04-23 ノビラ・ファーマシューティカルズ・インコーポレイテッド 薬剤を含む共晶溶媒、並びにその製造および使用方法
JP2022500446A (ja) * 2018-09-17 2022-01-04 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピックSociete D’Exploitation De Produits Pour Les Industries Chimiques Seppic 少なくとも１つの抗炎症物質を含む局所使用のための医薬組成物
JP7589144B2 (ja) 2018-09-17 2024-11-25 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピック 少なくとも１つの抗炎症物質を含む局所使用のための医薬組成物

Also Published As

Publication number Publication date
US7781429B2 (en) 2010-08-24
MXPA03008947A (es) 2005-04-19
US20040063794A1 (en) 2004-04-01
US20060211688A1 (en) 2006-09-21
CN1500524A (zh) 2004-06-02
US7138394B2 (en) 2006-11-21
US20050158348A1 (en) 2005-07-21
CN100534530C (zh) 2009-09-02

Similar Documents

Publication Publication Date Title
JP2004115525A (ja) 抗炎症性化合物の局所搬送用搬送剤
CN101790370B (zh) 一种新的双氯芬酸非水局部用溶液及其制备方法
Ahad et al. Chemical penetration enhancers: a patent review
CN106572970B (zh) 用于局部给药非甾体抗炎药以缓解肌肉骨骼疼痛的新型凝胶及其制备方法
US20060241175A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
AU2017240680A1 (en) Delivery system
JP4549006B2 (ja) ゲル軟膏
WO1997028793A1 (fr) Preparation a usage externe comprenant du tranilast et processus de production de cette preparation
JP2006528680A (ja) アルコールを含まない経皮鎮痛薬組成物およびその製造工程ならびに使用
JP5052558B2 (ja) ゲル軟膏
US20200301526A1 (en) Novel non-aqueous topical solution of diclofenac and process for preparing the same
EP1858556A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
Okyar et al. Novel formulation approaches for dermal and transdermal delivery of non-steroidal anti-inflammatory drugs
Panchal et al. TOPICAL EMULGEL: A REVIEW ON STATE OF ART.
RU2582278C2 (ru) Трансдермальное средство для лечения и профилактики болезней суставов и мягких тканей, способ его получения и комбинированный трансдермальный препарат для лечения и профилактики болезней суставов и мягких тканей
JP2012092067A (ja) 非ステロイド性消炎鎮痛外用剤
CA2500907A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
US20070042009A1 (en) Topical composition for delivery of salicylates
JPH11343248A (ja) 局所タ―ゲティング用組成物
US20130197092A1 (en) Novel Non-Aqueous Topical Solution of Diclofenac and Process for Preparing the Same
TR2021015125A2 (tr) Nonsteroi̇dal anti̇enflamatuvar bi̇r i̇lacin deri̇ye uygulanacak stabi̇l topi̇kal emüljel formülasyonlari
CA3186405A1 (en) Deep eutectic solvent including one or more active pharmaceutical ingredients derived from mushrooms
WO2024175915A1 (en) Compositions for topical administration
TR2024002454A1 (tr) Topical compositions comprising nimesulide and diclofenac sodium and a salicylate
JPH06184000A (ja) （−）−イソプレゴールからなる経皮吸収促進剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060928

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100309

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100608

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100611

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100708

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100713

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100806

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100811

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110208